Rybrevant

J&J MedTech Navigates Headwinds, Eyes Growth Surge in Second Half of 2024
J&J MedTech Navigates Headwinds, Eyes Growth Surge in Second Half of 2024
July 17, 2024  |  Healthcare

Johnson & Johnson’s (J&J) MedTech arm displayed resilience in its second quarter, navigating inflationary headwinds while prioritizing innovation. The unit, a key driver for J&J,...

READ MORE >